--- title: "SS Innovations International, Inc. (SSII.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/SSII.US.md" symbol: "SSII.US" name: "SS Innovations International, Inc." industry: "Health Care Equipment" --- # SS Innovations International, Inc. (SSII.US) | Item | Detail | |------|--------| | Industry | Health Care Equipment | | Location | US Market | | Website | [innovations.com](https://innovations.com) | ## Company Profile SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The ... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-25T04:30:13.000Z **Overall: B (0.40)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 26 / 185 | | Industry Median | C | | Industry Average | C | - **Style**: Growth - Stocks whose main business is in the growth stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 158.36% | | | Net Profit YoY | 60.57% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 24.32 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 964.23M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 36.07M | | **Multi Score**: B #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -43.42% | E | | Profit Margin | -32.11% | E | | Gross Margin | 48.05% | B | #### Growth Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 158.36% | A | | Net Profit YoY | 60.57% | B | | Total Assets YoY | 78.31% | A | | Net Assets YoY | 189.63% | A | #### Cash Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -311.47% | D | | OCF YoY | 158.36% | A | #### Operating Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.66 | B | #### Debt Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 43.01% | C | ```chart-data:radar { "title": "Longbridge Financial Score - SS Innovations International, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-43.42%", "rating": "E" }, { "name": "Profit Margin", "value": "-32.11%", "rating": "E" }, { "name": "Gross Margin", "value": "48.05%", "rating": "B" } ] }, { "name": "Growth", "grade": "A", "indicators": [ { "name": "Revenue YoY", "value": "158.36%", "rating": "A" }, { "name": "Net Profit YoY", "value": "60.57%", "rating": "B" }, { "name": "Total Assets YoY", "value": "78.31%", "rating": "A" }, { "name": "Net Assets YoY", "value": "189.63%", "rating": "A" } ] }, { "name": "Cash", "grade": "C", "indicators": [ { "name": "Cash Flow Margin", "value": "-311.47%", "rating": "D" }, { "name": "OCF YoY", "value": "158.36%", "rating": "A" } ] }, { "name": "Operating", "grade": "B", "indicators": [ { "name": "Turnover", "value": "0.66", "rating": "B" } ] }, { "name": "Security", "grade": "C", "indicators": [ { "name": "Gearing Ratio", "value": "43.01%", "rating": "C" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Inspire Medical (US.INSP) | A | B | A | A | B | A | | 02 | Delcath (US.DCTH) | C | A | A | A | A | A | | 03 | Abbott Laboratories (US.ABT) | B | C | C | B | C | B | | 04 | Intuitive Surgical (US.ISRG) | A | B | C | A | B | B | | 05 | Stryker (US.SYK) | A | B | C | C | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -83.27 | 166/181 | - | - | - | | PB | 24.32 | 131/181 | 122.98 | 31.10 | 26.15 | | PS (TTM) | 26.73 | 133/181 | 86.06 | 47.13 | 31.78 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/SSII.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/SSII.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/SSII.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.